Possible involvement of brain cytokines and 5-HT system in chronic fatigue syndrome

International Congress Series

Volumn 1287, Issue , 2006, Pages 251-255

  Katafuchi, Toshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

5 HT1A agonist; Chronic fatigue syndrome; Interferon ; Polyriboinosinic: polyribocytidylic acid (poly I:C); Running wheel; Serotonin transporter

Indexed keywords

EID: 33646555103     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.09.177     Document Type: Article

References (20)

1. Freeman R., and Komaroff A.L. Does the chronic fatigue syndrome involve the autonomic nervous system?. Am. J. Med. 102 (1997) 357-364
2. Glaser R., and Kiecolt-Glaser J.K. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am. J. Med. 105 (1998) 35S-42S
3. Whiteside T.L., and Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am. J. Med. 105 (1998) 27S-34S
4. Komaroff A.L. The biology of chronic fatigue syndrome. Am. J. Med. 108 (2000) 169-171 (comment)
5. Joyce E., Blumenthal S., and Wessely S. Memory, attention, and executive function in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 60 (1996) 495-503
6. Hori T., Katafuchi T., and Oka T. Central cytokines: effects on peripheral immunity, inflammation and nociception. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology (2001), Academic Press, San Diego 517-545
7. Rothwell N.J., and Hopkins S.J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18 (1995) 130-136 (comment)
8. Chao C.C., et al. Immunologically mediated fatigue: a murine model. Clin. Immunol. Immunopathol. 64 (1992) 161-165
9. Yamamoto T., and Newsholme E.A. Diminished central fatigue by inhibition of the L-system transporter for the uptake of tryptophan. Brain Res. Bull. 52 (2000) 35-38
10. Katafuchi T., et al. Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-α mRNA in rats: a model for immunologically induced fatigue. Neuroscience 120 (2003) 837-845
11. Morikawa O., et al. Effects of interferon-α, interferon-γ and cAMP on the transcriptional regulation of the serotonin transporter. Eur. J. Pharmacol. 349 (1998) 317-324
12. 3H]5-HT uptake into glial plasmalemmal vesicles. Neurochem. Int. 33 (1998) 11-22
13. Patarca R. Cytokines and chronic fatigue syndrome. Ann. N.Y. Acad. Sci. 933 (2001) 185-200
14. Davis J.M., et al. Immune system activation and fatigue during treadmill running: role of interferon. Med. Sci. Sports Exerc. 30 (1998) 863-868
15. Katafuchi T., Take S., and Hori T. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J. Physiol. (Lond.) 465 (1993) 343-357
16. Take S., et al. Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am. J. Physiol. 265 (1993) R453-R459
17. Katafuchi T., et al. Hypothalamic modulation of splenic natural killer cell activity in rats. J. Physiol. (Lond.) 471 (1993) 209-221
18. Take S., et al. Interferon-α acts at the preoptic hypothalamus to reduce natural killer cytotoxicity in rats. Am. J. Physiol. 268 (1995) (R-1406-R10)
19. Lloyd A., et al. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J. Infect. Dis. 164 (1991) 1023-1024
20. Narita M., et al. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem. Biophys. Res. Commun. 311 (2003) 264-266